RxDoctor Payments Data

Garhett Ulmer, NP

Nurse Practitioner · Boise, IDNPI 1619562295

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (54.8%), food and beverage and education — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Medtronic at 46.5% of the total. Reporting peaked in 2022 at $2,788 and has fallen 96.3% since, to $102 in 2025. Among nurse practitioner clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,928in general payments, 2019–2025

Across 84 payments — averaging $70.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Atricure, Inc.$2K
  • Biosense Webster, Inc.$704
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$251
  • E.r. Squibb & Sons, L.L.C.$157
  • Alnylam Pharmaceuticals Inc.$84
  • plus $151 from 6 others

What the payments were for

  • Travel & lodging$3,24655%
  • Food & beverage$2,66845%
  • Education$140%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,928 in reported general payments places this provider in the 95th percentile of 570 nurse practitioner providers in Idaho.

See all nurse practitioner providers in Idaho

Medicare billing

Part B allowed, 2024
$3,757
Medicare patients
128
Services billed
184

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban70$82,991
Dofetilide51$11,603
Metoprolol Succinate174$2,993
Sucralfate34$419
Pantoprazole Sodium71$332
SotalolSotalol Hcl16$266
Digoxin15$235
Amiodarone Hcl14$201
Carvedilol29$121
Spironolactone18$77
Montelukast Sodium11$39

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Boise

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →